Vitura Health Ltd
ASX:VIT
Vitura Health Ltd
ASX:VIT
Price:
0.038
AUD
-5%
Market Closed
Market Cap:
AU$25.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vitura Health Ltd
ASX:VIT
|
AU |
|
Riso Kagaku Corp
TSE:6413
|
JP |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
Daiki Aluminium Industry Co Ltd
TSE:5702
|
JP |
|
Adherium Ltd
ASX:ADR
|
NZ |
|
H
|
Hatcher Group Ltd
HKEX:8365
|
HK |
|
Laxmi Cotspin Ltd
NSE:LAXMICOT
|
IN |
|
Australian Clinical Labs Ltd
ASX:ACL
|
AU |
|
Bon-Ton Stores Inc
OTC:BONTQ
|
US |
|
Silex Systems Ltd
ASX:SLX
|
AU |
|
SBI Insurance Group Co Ltd
TSE:7326
|
JP |
Relative Value
The Relative Value of one
VIT
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 0.038 AUD,
Vitura Health Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VIT Relative Value
HIDDEN
Multiples Across Competitors
VIT Competitors Multiples
Vitura Health Ltd Competitors
Vitura Health Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Vitura Health Ltd
ASX:VIT
|
25.2m AUD | 0.2 | 34 | 11.6 | 11.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28.3 | 15.7 | 22.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5 | 20.2 | 12.5 | 16.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.1 | 7.5 | 8.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
